Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer delivered as a mesylate salt. It is the parental prodrug of trovafloxacin (Trovan) meant for intravenous administration. Trovafloxacin is a broad-spectrum antibiotic introduced in 1998 that encountered criticism for its Nigerian trials and adverse clinical reactions.Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in 2001.
This page contains content from the copyrighted Wikipedia article "Alatrofloxacin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.